PHOTO
- Blood Transfusion Medicine - a new addition to the Medlab conference agenda - to address the safe and effective collection, preparation and transfusion of blood
- Medlab Middle East takes place from 3-6 February at the Dubai World Trade Centre
According to Dr Raouf, only 0.6 per cent of the UAE population are AB negative, 1.8 per cent are B negative, 2.4 per cent are A negative, and 4 per cent are O negative. Positive blood types are the most common blood type and are found in 38.6 per cent of the population.
The 19th edition of the Medlab Middle East congress will feature 12 CME accredited multi-disciplinary conferences, including, a dedicated conference on Blood Transfusion Medicine.
The conference, which is supported by the International Society of Blood Transfusion and the Saudi Society of Transfusion Medicine, will feature several renowned international blood specialists presenting guidelines and regulatory updates on safe and effective collection, preparation and transfusion of blood products tailored for lab and transfusion specialists.
The conference, chaired by Dr May Raouf ,Head of blood donation center ,Dubai Health Authority and co-chaired by Dr Naema Omeziane, Medical Director, Abu Dhabi Blood Bank, SEHA, will examine critical topics including technological breakthroughs, global and regional challenges of recruitment and retention of blood donors, transfusion transmitted infections and screening of donors, amongst others.
– Ends –
About Medlab Middle East
Medlab Middle East stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Moving into its 4th year as a stand-alone show, this annual medical laboratory meeting brings together exhibitors and attendees from over 135+ countries, giving them the opportunity to present the latest innovations, as well as access cutting-edge laboratory products and services.
Medlab Middle East will take place from 3-6 February 2020 at the Dubai World Trade Centre, Dubai, UAE.
Website: www.medlabme.com
Facebook: www.facebook.com/medlabseries
Twitter: @MedlabSeries #MEDLABme
Instagram: @medlab.series
For more information, please contact Shamal Communications:
Media Contact
NATHALIE VISELE
Director
Tel: +971 4 365 2711 | Mobile : +971 50 457 6525
E-mail: nathalie.visele@shamalcomms.com
Office 106, Arjaan Office Tower, Dubai Media City
PO Box 502701 | Dubai, United Arab Emirates
Website: www.shamalcomms.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
